Labelling under EU MDR is no longer something manufacturers handle at the last stage. What goes on the label is checked carefully and compared against the technical file, clinical data, and intended use. Many review issues start here, which is why getting MDR labelling right early makes a real difference.
This page breaks down what medical device manufacturers need to know about EU MDR labelling — from high-level principles to practical considerations — to help avoid delays, rework, or non-compliance when accessing the European market.
Why Labeling Matters for Medical Devices in EU
When someone picks up a medical device, the label is the first thing they trust. It tells them what the device is, how it should be used, and what to watch out for. If that information isn’t clear, mistakes happen — not because the device failed, but because the message around it did.
In the EU, labeling is also where regulators start looking. They compare what’s written on the label with the device’s intended use, instructions, and technical file. Any mismatch raises questions. That’s why labeling is treated as part of compliance, not just packaging.
Labels don’t live alone. Instructions for use, patient information, symbols, and technical notes are all part of the same picture. Together, they guide safe use and support regulatory review.
What changed with EU MDR labeling
- EU MDR pushed labeling beyond the basics. Devices now need to be easier to trace, easier to understand, and clearer about who they are meant for.
- Most devices must carry a Unique Device Identifier. This helps track products across the supply chain and after they reach the market.
- Language also matters more than before. Information has to make sense in each country where the device is sold — not just exist as a translation.
- Symbols are still used, but they need to be current and appropriate. Older or unclear symbols can create confusion, especially for patients.
- Finally, MDR expects manufacturers to think about the end user. A surgeon, a nurse, and a patient at home don’t read labels the same way. Labels and instructions should reflect that difference.
EU Labeling considerations across different device classes
Devices under EU MDR aren’t all handled the same way, and labeling changes based on that. What appears on the label mainly depends on the device’s risk level. This risk classification, explained in Annex VIII, is what regulators use as their reference point during review.
Some devices need extra clarity. If a product is custom-made or intended only for clinical investigation, that purpose can’t be buried in documentation. It has to be visible on the label itself, so there’s no room for misunderstanding.
Material composition also matters. Devices that absorb, dissolve, or release substances in the body must explain what they’re made of and in what quantities. This isn’t about technical detail for its own sake — it’s about safety and transparency.
Single-use and sterile devices come with their own rules. If a device can be reprocessed, the label must say how many times, how it was sterilized, and whether it’s already been through that process.
There are also substances regulators watch closely. If a device contains CMR or endocrine-disrupting substances above the allowed threshold, this must be clearly stated. The same applies to products that include blood or tissue derivatives, even when they’re part of a combination device.
Also Read: Medical Device Regulations Under EU MDR
Labeling Documentation and Traceability
Under EU MDR, labeling is no longer treated as a static document. Regulators expect manufacturers to know exactly what is written on the label, where it is used, and when it was changed.
This means keeping clear records of:
- Approved label versions
- Language translations
- Change history across the product lifecycle
When a notified body asks how a label evolved over time, the answer should be easy to show, not reconstructed later.
How Clinical Evidence Influences Labels
What appears on a label is closely linked to clinical evidence, especially for higher-risk devices. Claims, instructions, and warnings are expected to reflect what clinical data actually supports.
When new clinical findings emerge, labeling may need adjustment. Ignoring that link — or updating one without the other — is a common reason devices attract regulatory attention.
Moving from MDD to EU MDR Labeling
For manufacturers already selling devices in Europe, EU MDR usually means reworking existing labels, not just updating a few symbols.
In practice, this involves reviewing:
- Instructions for Use (IFU)
- Symbols and warnings
- UDI placement and format
- Language coverage for target markets
Many companies discover gaps only when preparing for notified body review, which often leads to rework and timelines slipping.
Core Labeling Elements to Check Under EU MDR
Medical device identification
Labels must clearly identify the product as a medical device and show the device name or trade name consistently across packaging levels.
UDI requirements
Most devices require a UDI carrier on the label, presented in both machine-readable and human-readable formats. Higher packaging levels usually need their own UDI as well.
Electronic IFU (eIFU)
For certain device types, electronic IFUs may be used alongside paper instructions, provided the regulatory conditions are met.
Economic operator details
The label must include manufacturer information. For non-EU manufacturers, authorized representative details are also required.
Warnings and precautions
Key safety information must appear on the label, with more detailed explanations placed in the IFU where appropriate.
Country-specific language needs
Language matters too. Each EU country has its own expectations, and missing or incorrect translations can lead to market restrictions or corrective actions.
Also Read: Medical Device Risk Classification Under EU MDR
EU MDR labeling is often underestimated until it becomes a blocker. In practice, labels are one of the first things reviewers look at — and one of the easiest places to spot inconsistencies. Learn more about how we support manufacturers under EU MDR on our EU Regulatory Services and contact us at info@artixio.com.